ATE399204T1 - Humanes endogenes retrovirus - Google Patents

Humanes endogenes retrovirus

Info

Publication number
ATE399204T1
ATE399204T1 AT00946988T AT00946988T ATE399204T1 AT E399204 T1 ATE399204 T1 AT E399204T1 AT 00946988 T AT00946988 T AT 00946988T AT 00946988 T AT00946988 T AT 00946988T AT E399204 T1 ATE399204 T1 AT E399204T1
Authority
AT
Austria
Prior art keywords
mtv
human
endogene
retrovirus
present
Prior art date
Application number
AT00946988T
Other languages
English (en)
Inventor
Robert F Garry
Original Assignee
Univ Tulane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tulane filed Critical Univ Tulane
Application granted granted Critical
Publication of ATE399204T1 publication Critical patent/ATE399204T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/10022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/12011Betaretrovirus, e.g. mouse mammary tumour virus
    • C12N2740/12022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/826Viruses
AT00946988T 1999-06-30 2000-06-30 Humanes endogenes retrovirus ATE399204T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14162699P 1999-06-30 1999-06-30

Publications (1)

Publication Number Publication Date
ATE399204T1 true ATE399204T1 (de) 2008-07-15

Family

ID=22496493

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00946988T ATE399204T1 (de) 1999-06-30 2000-06-30 Humanes endogenes retrovirus

Country Status (14)

Country Link
US (1) US6670466B1 (de)
EP (1) EP1190055B1 (de)
JP (1) JP4934258B2 (de)
AT (1) ATE399204T1 (de)
AU (1) AU778027B2 (de)
CA (1) CA2369848C (de)
DE (1) DE60039295D1 (de)
DK (1) DK1190055T3 (de)
ES (1) ES2307521T3 (de)
HK (1) HK1046535B (de)
MX (1) MXPA01013388A (de)
NO (1) NO331637B1 (de)
PT (1) PT1190055E (de)
WO (1) WO2001000829A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100440852B1 (ko) * 2001-05-10 2004-07-19 주식회사 바이로메드 레트로바이러스에 특이적인 올리고뉴클레오티드 프라이머및 이를 이용한 레트로바이러스 농도 측정방법
US7056731B1 (en) 2001-06-22 2006-06-06 Mayo Foundation For Medical Education And Research Sulfotransferase SULT2A1 sequence variants
DE10309368A1 (de) * 2002-08-06 2004-02-26 Aventis Behring Gmbh Intellectual Property/Legal Pharmazeutische Zubereitung mit RNA als Cofaktor der Hämostase
ES2334149T3 (es) * 2004-01-21 2010-03-05 Gilead Sciences, Inc. Uso de adefovir o tenofovir para inhibir virus de tipo vtmr implicados en el cancer de mama y en la cirrosis biliar primaria.
WO2005073728A1 (en) * 2004-01-29 2005-08-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method for diagnosing and treatment of breast cancer and pharmaceuticals copmsition and kit for same
US20070110760A1 (en) * 2005-01-14 2007-05-17 Monroe John G Methods and compositions targeting viral and cellular ITAM motifs, and use of same in identifying compounds with therapeutic activity
US20090297530A1 (en) * 2006-05-22 2009-12-03 Feng Wang-Johanning Herv-k antigens, antibodies, and methods
CN105838737A (zh) * 2010-01-28 2016-08-10 费城儿童医院 用于病毒载体纯化的可扩缩生产平台和用于基因治疗中的如此纯化的病毒载体
US20190343938A1 (en) * 2019-07-02 2019-11-14 Virago Vax Inc. Mammary tumor virus vaccine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686247A (en) 1995-11-09 1997-11-11 Mount Sinai School Of Medicine Of The City University Of New York Detection of mammary tumor virus env gene-like sequences in human breast cancer

Also Published As

Publication number Publication date
NO331637B1 (no) 2012-02-13
PT1190055E (pt) 2008-09-03
JP4934258B2 (ja) 2012-05-16
CA2369848C (en) 2011-09-20
EP1190055B1 (de) 2008-06-25
WO2001000829A9 (en) 2002-07-25
DK1190055T3 (da) 2008-09-22
WO2001000829A8 (en) 2001-06-14
ES2307521T3 (es) 2008-12-01
AU778027B2 (en) 2004-11-11
CA2369848A1 (en) 2001-01-04
WO2001000829A2 (en) 2001-01-04
HK1046535A1 (en) 2003-01-17
NO20016296D0 (no) 2001-12-20
HK1046535B (zh) 2009-02-27
NO20016296L (no) 2002-02-25
EP1190055A2 (de) 2002-03-27
US6670466B1 (en) 2003-12-30
MXPA01013388A (es) 2002-07-02
AU6066700A (en) 2001-01-31
WO2001000829A3 (en) 2002-01-10
DE60039295D1 (de) 2008-08-07
JP2003507050A (ja) 2003-02-25

Similar Documents

Publication Publication Date Title
ATE446365T1 (de) Menschliches fgf-21 gen und genexpressionsprodukte
PT93393A (pt) Processo para a preparacao de vacinas e de agentes de diagnostico que contem regioes imunogenicas de proteina e7do virus do papiloma humano do tipo 16 ou anticorpos suscitados contra estas regioes
ATE399204T1 (de) Humanes endogenes retrovirus
DE69435075D1 (de) , die signalsequenzpeptide des endoplasmatischen reticulums und mindestens ein anderes peptid codieren, deren verwendung in impfstoffen und zur behandlung von krankheiten
DK0702085T3 (da) Rekombinant infektiøs ikke-segmenteret negativ-strenget RNA-virus
DE602004009705D1 (de) Methoden der Verhinderung und Behandlung der Alzheimer'schen Krankheit
ATE141946T1 (de) Hiv-2-virusvarianten
NZ531570A (en) DNA sequences for human angiogenesis genes
FI911212A0 (fi) Protein med uratoxidasaktivitet, rekombinantgen som kodar detta, expressionsvektor, mikroorganismer och transformerade celler.
ATE482272T1 (de) Zytokinproteinfamilie
DE60127715D1 (de) Polypeptide zur auslösung einer immunreaktion gegen krebs
WO2001043693A3 (en) Polynucleotide vaccines expressing codon optimized hiv-1 nef and modified hiv-1 nef
PT1417222E (pt) Polipéptidos isolados baseados no epítopo neutralizante da proteína p17 de vih, úteis como vacinas, e anticorpos antip17 neutralizantes que reconhecem especificamente o referido polipéptido neutralizante
DE69818913D1 (de) Rekombinanter Birnavirusimpfstoff
TR200000610T2 (tr) IL-8 reseptör karşıtları.
DE69619683D1 (de) Expression von heterologen genen in menschlichen brustzellen, einschliesslich menschliche brustkarzionomzellen unter der kontrolle von regulatorischen sequenzen von wap oder mmtv
TR199701666A2 (xx) �i�manl��a kar�� proteinler
HU896176D0 (en) Method for producing of protease, reverse transcriptase and endonuclease of retrovirus
NO874704D0 (no) Minaktivin fremstilt ved rekombinant dna-teknikk.
ATE344802T1 (de) Angiogenese-assoziierte proteine und dafür kodierende nukleinsäure
ATE323772T1 (de) Regulatorische sequenzen des humanen mcp-1 gens
ATE292185T1 (de) Rekombinantes mva mit der fähigkeit zur expression des her-2/neu-gens
UA88601C2 (ru) Промотор il-18bp, его получение и применение
ATE544784T1 (de) Als cytotoxin geeignetes fusionspolypeptid
CY1116483T1 (el) Εμβολιο χοιρειου κυκλοϊου σε ανασυνδυασμενο ιο της ευλογιας

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1190055

Country of ref document: EP